Live feed09:27:00·39mNEWSReleasevia QuantisnowAs Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in CongoByQuantisnow·Wall Street's wire, on your screen.NNVC· NanoViricides Inc.Health Care
